iRay Technology Hits Day Low of CNY 108.14 Amid Price Pressure

iRay Technology Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.14% on March 23, 2026. The stock reached an intraday low of CNY 108.14, reflecting a challenging trading day. Over the past week, iRay has seen a decrease of 5.63%, while its performance over the last month shows a decline of 9.1%. Despite these short-term setbacks, iRay Technology has demonstrated a strong annual performance, boasting a return of 44.85% over the past year, significantly outperforming the China Shanghai Composite, which recorded a return of 13.33%. However, the company has faced difficulties in recent quarters, reporting negative results for three consecutive periods. Financial metrics indicate a high valuation with a Price to Book ratio of 4.69 and a P/E ratio of 48.00. The company's return on equity stands at 9.68%, while its dividend yield is currently at 0.59%. As iRay Technology navigates these fluctuations, its market capitalization remains robust at CNY 24,130 million, positioning it as a large-cap entity within its industry.